| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |